Scaling Up Molecular Diagnostic Tests for Drug-Resistant Tuberculosis in Uzbekistan from 2012–2019: Are We on the Right Track?

Uzbekistan has a large burden of drug-resistant tuberculosis (TB). To deal with this public health threat, the National TB Program introduced rapid molecular diagnostic tests such as Xpert MTB/RIF (Xpert) and line probe assays (LPAs) for first-line and second-line drugs. We documented the scale-up o...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuldashev, Sharofiddin, Parpieva, Nargiza, Alimov, Salikhdjan, Turaev, Laziz, Safaev, Khasan, Dumchev, Kostyantyn, Gadoev, Jamshid, Korotych, Oleksandr, Harries, Anthony D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124440/
https://www.ncbi.nlm.nih.gov/pubmed/33924862
http://dx.doi.org/10.3390/ijerph18094685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124440/
https://www.ncbi.nlm.nih.gov/pubmed/33924862
http://dx.doi.org/10.3390/ijerph18094685

Ejemplares similares